Triple-negative Breast Cancer (TNBC): Neoadjuvant Benefits of Tecentriq® increases the pCR-Rate

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
    Yu, Y.
    Zhang, J.
    Lin, Y.
    Kang, S.
    Lv, X.
    Song, C.
    BREAST, 2021, 56 : S50 - S50
  • [32] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy
    Ryan, P. D.
    Tung, N. M.
    Isakoff, S. J.
    Golshan, M.
    Richardson, A.
    Corben, A. D.
    Smith, B. L.
    Gelman, R.
    Winer, E. P.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
    Abeer H. Abdelhafez
    Benjamin C. Musall
    Beatriz E. Adrada
    KennethR. Hess
    Jong Bum Son
    Ken-Pin Hwang
    Rosalind P. Candelaria
    Lumarie Santiago
    Gary J. Whitman
    Huong T. Le-Petross
    Tanya W. Moseley
    Elsa Arribas
    Deanna L. Lane
    Marion E. Scoggins
    Jessica W. T. Leung
    Hagar S. Mahmoud
    Jason B. White
    Elizabeth E. Ravenberg
    Jennifer K. Litton
    Vicente Valero
    Peng Wei
    Alastair M. Thompson
    Stacy L. Moulder
    Mark D. Pagel
    Jingfei Ma
    Wei T. Yang
    Gaiane M. Rauch
    Breast Cancer Research and Treatment, 2021, 185 : 1 - 12
  • [35] Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
    Abdelhafez, Abeer H.
    Musall, Benjamin C.
    Adrada, Beatriz E.
    Hess, KennethR.
    Son, Jong Bum
    Hwang, Ken-Pin
    Candelaria, Rosalind P.
    Santiago, Lumarie
    Whitman, Gary J.
    Le-Petross, Huong T.
    Moseley, Tanya W.
    Arribas, Elsa
    Lane, Deanna L.
    Scoggins, Marion E.
    Leung, Jessica W. T.
    Mahmoud, Hagar S.
    White, Jason B.
    Ravenberg, Elizabeth E.
    Litton, Jennifer K.
    Valero, Vicente
    Wei, Peng
    Thompson, Alastair M.
    Moulder, Stacy L.
    Pagel, Mark D.
    Ma, Jingfei
    Yang, Wei T.
    Rauch, Gaiane M.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 1 - 12
  • [36] Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
    Moore-Smith, Lakisha
    Forero-Torres, Andres
    Stringer-Reasor, Erica
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 773 - +
  • [37] Triple-negative breast cancer: Neoadjuvant durvalumab improves prognosis
    Kunzell, Judith Lorenz
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (02)
  • [38] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [39] Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
    Denkert, Carsten
    Schneeweiss, Andreas
    Rey, Julia
    Karn, Thomas
    Hattesohl, Akira
    Weber, Karsten E.
    Rachakonda, Sivaramakrishna
    Braun, Michael
    Huober, Jens
    Jank, Paul
    Sinn, Hans-Peter
    Zahm, Dirk-Michael
    Felder, Barbel
    Hanusch, Claus
    Teply-Szymanski, Julia
    Marme, Frederik
    Fehm, Tanja
    Thomalla, Jorg
    V. Sinn, Bruno
    Stiewe, Thorsten
    Marczyk, Michal
    Blohmer, Jens-Uwe
    van Mackelenbergh, Marion
    Schem, Christian
    Staib, Peter
    Link, Theresa
    Muller, Volkmar
    Stickeler, Elmar
    Stover, Daniel G.
    Solbach, Christine
    Metzger-Filho, Otto
    Jackisch, Christian
    Geyer Jr, Charles E.
    Fasching, Peter A.
    Pusztai, Lajos
    Nekljudova, Valentina
    Untch, Michael
    Loibl, Sibylle
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [40] Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
    Fitzpatrick, Amanda
    Tutt, Andrew
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
12345